Studies // Cited work
Rumination-focused cognitive–behavioural therapy for residual depression: Phase II randomised controlled trial
Watkins, E. R., Mullan, E., Wingrove, J., Rimes, K., Steiner, H., Bathurst, N., Eastman, R., & Scott, J. (2011). Rumination-focused cognitive–behavioural therapy for residual depression: Phase II randomised controlled trial.
Level B Experiment doi:10.1192/bjp.bp.110.090282
What this study supports
Supports the claim that adding rumination-focused CBT improved residual symptoms and remission, mediated by change in rumination. Phase II trial without an attentional control, so specific and non-specific effects cannot be separated.
- Who was studied
- 42 adults with medication-refractory residual depression randomised to treatment as usual or treatment as usual plus rumination-focused CBT.
- Design
- Experiment
- Level of evidence
- Controlled studies: randomised or experimental designs, and syntheses of correlational work.
Claims that rest on it
Each claim states what the site asserts, at what strength, and with what caveat.
EmpiricalLevel BConfidence LOW
Adding rumination-focused cognitive-behavioural therapy to usual treatment improved residual depressive symptoms and remission in a small randomised trial, with effects mediated by change in rumination.
- Scope
- 42 adults with medication-refractory residual depression.
- Caveat
- A phase II trial without an attentional control, so specific and non-specific therapy effects cannot be separated; a clinical treatment, not self-help.
Last reviewed · Review due · rumination-focused-therapy-trial